EUVIMEDEUVIMED entdecken
Crossref

The PDE3-specific inhibitor milrinone improves asthenozoospermic sperm function by regulating cAMP–PKA signaling pathway and energy metabolism

Luchen Xu, Wei Ma, Chunyan Liu, Qinglian He, Zaoya Zhao, Xiaoli Qu, Qianxing Zou iD

Reproduction, Fertility and Development · 2026

DOI: 10.1071/rd26057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproduction, Fertility and Development, 2026. Verfasst von Luchen Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Green Processing of Sugar Resources, College of Biological and Chemical Engineering, Guangxi University of Science and Tech…. Hauptthemen laut MEDLINE: Milrinone, Asthenozoospermia, Cyclic AMP, Energy Metabolism. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Inhibiting phosphodiesterase (PDE) activity to increase cyclic adenosine monophosphate (cAMP) concentrations is a core strategy in artificial sperm activation. PDE3, a key member of the PDE family, comprises two subtypes, PDE3A and PDE3B. However, their specific expression patterns and functions in human sperm remain incompletely understood.

Aims

To analyze the expression characteristics of PDE3A and PDE3B in human sperm and investigate the regulatory effects of PDE3 inhibitor milrinone on asthenozoospermic sperm function and the related mechanisms.

Methods

The expression of PDE3A and PDE3B was detected using reverse transcription polymerase chain reaction (RT–PCR), western blot and immunofluorescence. Changes in asthenozoospermic sperm functions after milrinone treatment were detected using computer-assisted sperm analysis (CASA), methylcellulose viscous penetration assay, and fluorescein isothiocyanate–conjugated peanut agglutinin (FITC–PNA) staining. Moreover, intracellular factors closely correlated with sperm function regulation were measured using enzyme-linked immunosorbent assay (ELISA), flow cytometry, and metabolome analysis. Key results PDE3B expression level was greater than was the expression level of PDE3A in human sperm. Sperm function analysis showed that milrinone significantly enhanced asthenozoospermic sperm motility, mucus penetration ability, and the acrosome reaction. With respect to intracellular signals, milrinone activated the cAMP‒protein kinase A (PKA) signaling pathway, and metabolomic analysis showed that milrinone-induced differentially abundant metabolites (DAMs) were associated with the citrate cycle and fatty acid degradation pathways, suggesting that it regulates energy metabolism.

Conclusions

These results demonstrated that milrinone primarily targets PDE3B to improve asthenozoospermic sperm function by regulating cAMP‒PKA signaling pathway and energy metabolism.

Implications

The present study has gained new insight into the molecular basis of cAMP signaling regulation in human sperm and provides theoretical and experimental support for the potential application of milrinone for asthenozoospermic sperm activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MilrinoneAsthenozoospermiaCyclic AMPEnergy MetabolismPhosphodiesterase 3 InhibitorsCyclic Nucleotide Phosphodiesterases, Type 3SpermatozoaCyclic AMP-Dependent Protein KinasesMaleHumansSignal TransductionSperm MotilitySperm ProteinsAcrosome Reaction

Stichwörter der Autor:innen

PDE3Bacrosome reactionasthenozoospermiacAMP‒PKA signaling pathwayenergy metabolismmilrinonephosphodiesterase inhibitorsperm motility

Substanzen

MilrinoneCyclic AMPPhosphodiesterase 3 InhibitorsCyclic Nucleotide Phosphodiesterases, Type 3Cyclic AMP-Dependent Protein KinasesPDE3B protein, humanPDE3A protein, humanSperm Proteins

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Green Processing of Sugar Resources, College of Biological and Chemical Engineering, Guangxi University of Science and Technology, Liuzhou 545006, PR China.
  • Department of Clinical Laboratory, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou 545006, PR China.
  • Department of Reproductive Medicine, Liuzhou People's Hospital affiliated to Guangxi Medical University, Liuzhou 545006, PR China.

ORCID-Profile: Qianxing Zou

Zitieren

APA

Xu, L., Ma, W., Liu, C., He, Q., Zhao, Z., Qu, X., & Zou, Q. (2026). The PDE3-specific inhibitor milrinone improves asthenozoospermic sperm function by regulating cAMP–PKA signaling pathway and energy metabolism. Reproduction, Fertility and Development. https://doi.org/10.1071/rd26057

Vancouver

Xu L, Ma W, Liu C, He Q, Zhao Z, Qu X, et al. The PDE3-specific inhibitor milrinone improves asthenozoospermic sperm function by regulating cAMP–PKA signaling pathway and energy metabolism. Reproduction, Fertility and Development. 2026. doi:10.1071/rd26057

BibTeX
@article{Xu2026,
  author = {Xu, Luchen and Ma, Wei and Liu, Chunyan and He, Qinglian and Zhao, Zaoya and Qu, Xiaoli and Zou, Qianxing},
  title = {The PDE3-specific inhibitor milrinone improves asthenozoospermic sperm function by regulating cAMP–PKA signaling pathway and energy metabolism},
  journal = {Reproduction, Fertility and Development},
  year = {2026},
  doi = {10.1071/rd26057}
}
Kostenlos starten →